Abstract Background There were few related studies aiming to severe IgA nephropathy (IgAN) which could progress rapidly to end stage renal disease (ESRD) within ten years. To find valuable clinical or pathological factors and promising precautions is essential. Methods A single center case\u2013control study was performed. Fifty ESRD patients with the primary cause of IgAN and a short renal survival time of less than ten years after diagnose were enrolled in the case group. One hundred IgAN patients with a renal survival time of more than ten years were enrolled in the control group. IgA Oxford classifi...
Little is known about the long-term prognosis of patients with IgA nephropathy (IgAN).This retrospec...
We determined the natural history of IgA nephropathy (IgAN) among patients who presented with protei...
BACKGROUND: IgA nephropathy can progress to kidney failure, and risk assessment soon after diagnosis...
A retrospective study of 223 patients with IgA nephropathy (IgAN) was performed to clarify the progn...
Background: There is a need for early identification of children with immunoglobulin A nephropathy (...
<div><p>IgA nephropathy (IgAN) is a common cause of end-stage renal disease (ESRD) in Asia. In this ...
BACKGROUND: There is a need for early identification of children with immunoglobulin A nephropathy...
IgA nephropathy (IgAN) is a common cause of end-stage renal disease (ESRD) in Asia. In this study, b...
IgA nephropathy (IgAN) is a common cause of end-stage renal disease (ESRD) in Asia. In this study, b...
IntroductionIgA nephropathy (IgAN) has a heterogeneous presentation and the progression to end stage...
Background: Patients with immunoglobulin A (IgA) nephropathy may progress to end-stage renal diseas...
Background: Patients with immunoglobulin A (IgA) nephropathy may progress to end-stage renal diseas...
Research on the prognosis of IgA nephropathy (IgAN) has focused on renal survival, with little infor...
Background and objectives Current therapy for IgA nephropathy mainly includes renin-angiotensin s...
Little is known about the long-term prognosis of patients with IgA nephropathy (IgAN).This retrospec...
Little is known about the long-term prognosis of patients with IgA nephropathy (IgAN).This retrospec...
We determined the natural history of IgA nephropathy (IgAN) among patients who presented with protei...
BACKGROUND: IgA nephropathy can progress to kidney failure, and risk assessment soon after diagnosis...
A retrospective study of 223 patients with IgA nephropathy (IgAN) was performed to clarify the progn...
Background: There is a need for early identification of children with immunoglobulin A nephropathy (...
<div><p>IgA nephropathy (IgAN) is a common cause of end-stage renal disease (ESRD) in Asia. In this ...
BACKGROUND: There is a need for early identification of children with immunoglobulin A nephropathy...
IgA nephropathy (IgAN) is a common cause of end-stage renal disease (ESRD) in Asia. In this study, b...
IgA nephropathy (IgAN) is a common cause of end-stage renal disease (ESRD) in Asia. In this study, b...
IntroductionIgA nephropathy (IgAN) has a heterogeneous presentation and the progression to end stage...
Background: Patients with immunoglobulin A (IgA) nephropathy may progress to end-stage renal diseas...
Background: Patients with immunoglobulin A (IgA) nephropathy may progress to end-stage renal diseas...
Research on the prognosis of IgA nephropathy (IgAN) has focused on renal survival, with little infor...
Background and objectives Current therapy for IgA nephropathy mainly includes renin-angiotensin s...
Little is known about the long-term prognosis of patients with IgA nephropathy (IgAN).This retrospec...
Little is known about the long-term prognosis of patients with IgA nephropathy (IgAN).This retrospec...
We determined the natural history of IgA nephropathy (IgAN) among patients who presented with protei...
BACKGROUND: IgA nephropathy can progress to kidney failure, and risk assessment soon after diagnosis...